Table 2 Clinical outcomes of critically ill patients with COVID-19 after PS matching
Outcomes | Number of outcomes/Total number of patients | Â | Odds Ratio (OR) (95%CI) | P-value $ | |
|---|---|---|---|---|---|
DEX (n = 24) | mPRED (n = 24) | P-value | |||
30-day mortality, n (%) | 3 ( 14.3) | 6 ( 31.6) | 0.19** | 2.36 (0.51,10.86) | 0.27 |
In-hospital mortality, n (%) | 4 ( 18.2) | 7 ( 35.0) | 0.22^^ | 2.31 (0.56,9.59) | 0.25 |
| Â | Â | Â | Â | beta coefficient (Estimates) (95%CI) | P-value $* |
Ventilator free days, Median (Q1, Q3) | 20.0 (4.00, 25.00) | 15.0 (0.00, 23.00) | 0.38^ | -0.20 (-0.99,0.60) | 0.63 |
ICU Length of Stay (Days), Median (Q1,Q3) | 13.0 (6.00, 21.00) | 15.5 (9.00, 23.00) | 0.53^ | 0.34 (-0.10,0.77) | 0.13 |
Hospital Length of Stay (Days), Median (Q1,Q3) | 21.5 (11.50, 29.00) | 19.5 (15.50, 29.50) | 0.81^ | 0.06 (-0.35,0.47) | 0.76 |